The effects of intramuscular administration of scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled trial.
Ther Adv Psychopharmacol
; 10: 2045125320938556, 2020.
Article
in En
| MEDLINE
| ID: mdl-32655854
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Prognostic_studies
Language:
En
Journal:
Ther Adv Psychopharmacol
Year:
2020
Document type:
Article
Affiliation country:
China